Masaru Kuroda, MD, PhD; Eiji Tamiya, MD, PhD; Takahisa Nose, MD, PhD; et al.
open access
JAMA Cardiol. 2022;7(6):583-590. doi:10.1001/jamacardio.2022.0480
This randomized clinical trial investigates the effect of 15-mg edoxaban in patients aged 80 years and older who are not candidates for standard-dose oral anticoagulants owing to bleeding risk.
Jennifer Lewey, MD, MPH; Samantha Murphy, BA; Dazheng Zhang, MS; et al.
free access
JAMA Cardiol. 2022;7(6):591-599. doi:10.1001/jamacardio.2022.0553
This randomized clinical trial determines whether a digital health intervention can improve physical activity in postpartum individuals with hypertensive disorders of pregnancy.
Øystein Karlstad, MScPharm, PhD; Petteri Hovi, MD, PhD; Anders Husby, MD, PhD; et al.
open access
has active quiz
JAMA Cardiol. 2022;7(6):600-612. doi:10.1001/jamacardio.2022.0583
This cohort study conducted using nationwide registers assesses the risks of myocarditis and pericarditis after SARS-CoV-2 messenger RNA vaccinations in a combined population of 23.1 million individuals across Denmark, Finland, Norway, and Sweden.
-
Editor's Note
Communicating the Benefits of Vaccination in Light of Potential Risks
Ann Marie Navar, MD, PhD; Robert O. Bonow, MD
JAMA Cardiol
Yun Wang, PhD; Erica C. Leifheit, PhD; Harlan M. Krumholz, MD, SM
free access
JAMA Cardiol. 2022;7(6):613-622. doi:10.1001/jamacardio.2022.0662
This cohort study evaluates trends in 10-year all-cause mortality and hospitalization for recurrent acute myocardial infarction by demographic subgroups and examines the association between recurrence and mortality.
Peder L. Myhre, MD, PhD; Brian Claggett, PhD; Bing Yu, PhD; et al.
free access
has audio
JAMA Cardiol. 2022;7(6):623-631. doi:10.1001/jamacardio.2022.0680
This cohort study aims to determine whether physiologic determinants of N-terminal pro鈥揃-type natriuretic peptide concentrations account for sex and race differences and aims to more uniformly predict heart failure risk.
-
Podcast:
Sex and Race Differences in NT-proBNP Concentration and Absolute Risk of Heart Failure in the Community
-
Editor's Note
Who Is at Risk for Heart Failure?
Clyde W. Yancy, MD, MSc; Sadiya S. Khan, MD, MSc
JAMA Cardiol
Simon A. Amacher, MD; Chantal Bohren, MBBS, BSc; René Blatter, MMed; et al.
free access
JAMA Cardiol. 2022;7(6):633-643. doi:10.1001/jamacardio.2022.0795
This meta-analysis of patients with out-of-hospital cardiac arrest assesses the long-term survival rate in those who survive the initial hospital stay.
-
Invited Commentary
Treatment of Out-of-Hospital Cardiac Arrest
Jean Baptiste Lascarrou, MD, PhD; Graham Nichol, MD, MPH
JAMA Cardiol